These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10858434)

  • 21. Pharmacological characterization of FE 202158, a novel, potent, selective, and short-acting peptidic vasopressin V1a receptor full agonist for the treatment of vasodilatory hypotension.
    Laporte R; Kohan A; Heitzmann J; Wisniewska H; Toy J; La E; Tariga H; Alagarsamy S; Ly B; Dykert J; Qi S; Wisniewski K; Galyean R; Croston G; Schteingart CD; Rivière PJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):786-96. PubMed ID: 21411496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ERK2 mediates oxytocin-stimulated PGE2 synthesis.
    Strakova Z; Copland JA; Lolait SJ; Soloff MS
    Am J Physiol; 1998 Apr; 274(4):E634-41. PubMed ID: 9575824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.
    Thibonnier M; Auzan C; Madhun Z; Wilkins P; Berti-Mattera L; Clauser E
    J Biol Chem; 1994 Feb; 269(5):3304-10. PubMed ID: 8106369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desensitisation of the oxytocin receptor and other G-protein coupled receptors in the human myometrium.
    Plested CP; Bernal AL
    Exp Physiol; 2001 Mar; 86(2):303-12. PubMed ID: 11429648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the human V1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction.
    Thibonnier M; Plesnicher CL; Berrada K; Berti-Mattera L
    Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E81-92. PubMed ID: 11404225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G protein-coupled receptor kinase specificity for phosphorylation and desensitization of alpha2-adrenergic receptor subtypes.
    Jewell-Motz EA; Liggett SB
    J Biol Chem; 1996 Jul; 271(30):18082-7. PubMed ID: 8663433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C.
    Oppermann M; Freedman NJ; Alexander RW; Lefkowitz RJ
    J Biol Chem; 1996 May; 271(22):13266-72. PubMed ID: 8662816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of the sites for Ca2+-binding proteins on G protein-coupled receptor kinases.
    Levay K; Satpaev DK; Pronin AN; Benovic JL; Slepak VZ
    Biochemistry; 1998 Sep; 37(39):13650-9. PubMed ID: 9753452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phospholipid-stimulated autophosphorylation activates the G protein-coupled receptor kinase GRK5.
    Kunapuli P; Gurevich VV; Benovic JL
    J Biol Chem; 1994 Apr; 269(14):10209-12. PubMed ID: 8144599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple mechanisms involving protein phosphorylation are linked to desensitization of muscarinic receptors.
    Hosey MM; Benovic JL; DebBurman SK; Richardson RM
    Life Sci; 1995; 56(11-12):951-5. PubMed ID: 10188798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The proximal portion of the COOH terminus of the oxytocin receptor is required for coupling to g(q), but not g(i). Independent mechanisms for elevating intracellular calcium concentrations from intracellular stores.
    Hoare S; Copland JA; Strakova Z; Ives K; Jeng YJ; Hellmich MR; Soloff MS
    J Biol Chem; 1999 Oct; 274(40):28682-9. PubMed ID: 10497238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of G protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain.
    Pronin AN; Satpaev DK; Slepak VZ; Benovic JL
    J Biol Chem; 1997 Jul; 272(29):18273-80. PubMed ID: 9218466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation and recycling kinetics of G protein-coupled receptors.
    Innamorati G; Sadeghi H; Birnbaumer M
    J Recept Signal Transduct Res; 1999; 19(1-4):315-26. PubMed ID: 10071767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors.
    Pena A; Murat B; Trueba M; Ventura MA; Bertrand G; Cheng LL; Stoev S; Szeto HH; Wo N; Brossard G; Serradeil-Le Gal C; Manning M; Guillon G
    Endocrinology; 2007 Sep; 148(9):4136-46. PubMed ID: 17495006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2.
    Hasbi A; Devost D; Laporte SA; Zingg HH
    Mol Endocrinol; 2004 May; 18(5):1277-86. PubMed ID: 14976224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase A and G protein-coupled receptor kinase phosphorylation mediates beta-1 adrenergic receptor endocytosis through different pathways.
    Rapacciuolo A; Suvarna S; Barki-Harrington L; Luttrell LM; Cong M; Lefkowitz RJ; Rockman HA
    J Biol Chem; 2003 Sep; 278(37):35403-11. PubMed ID: 12821660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.
    Chini B; Mouillac B; Ala Y; Balestre MN; Cotte N; Trumpp-Kallmeyer S; Hoflack J; Elands J; Hibert M; Manning M
    Adv Exp Med Biol; 1995; 395():321-8. PubMed ID: 8713982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor and G betagamma isoform-specific interactions with G protein-coupled receptor kinases.
    Daaka Y; Pitcher JA; Richardson M; Stoffel RH; Robishaw JD; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2180-5. PubMed ID: 9122168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional interactions between the oxytocin receptor and the β2-adrenergic receptor: implications for ERK1/2 activation in human myometrial cells.
    Wrzal PK; Goupil E; Laporte SA; Hébert TE; Zingg HH
    Cell Signal; 2012 Jan; 24(1):333-41. PubMed ID: 21964067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.